Medical Brands has received the status "Product Class IIb" for his medical device for self- treatment of urinary tract infections from European Union.
The competent authorities of other members on the basis of recent tests and studies the status of " product class IIb " for the development of Medical Brands medical device for self- treatment of urinary tract infections. With this status, the permanent deployment of the product for the prevention of urinary tract infections over a period of 30 days is also permitted.
Urinary tract infections (UTIs) are a serious health problem that affects the annual million people. Today, they are usually treated with antibiotics , but as more and more pathogens are becoming resistant to antibiotics, is sought worldwide feverishly for alternatives. The product of Medical Brands to combat urinary tract infections is to meet this growing demand.
Cranberry -Active is the only one in the medical device class IIb registered product may be sold freely on cranberry base in the European Economic Area, and in certain other countries, to be with the indication medically effective for the treatment of urinary tract infections and their prevention. The product has been clinically tested, does not stress the body, works immediately and can be used daily.
Medical Brands is looking for partners for the marketing of the Cranberry -Active bubble capsules in Europe and coordinated countries.
Medical Brands provides consumers with medical devices for self- treatment of minor, often occurring at Leiden. Medical Brands developed patents and registered products for the treatment of simple, everyday diseases and their prevention without pharmacological effect and sells products that are registered as medical devices.